CONTOUR® PLUS BLUE Blood Glucose Monitoring System +2 more— 510(k) K260545

Substantially Equivalent

Ascensia Diabetes Care

FDA 510(k) clearance K260545 for CONTOUR® PLUS BLUE Blood Glucose Monitoring System +2 more, Substantially Equivalent on 2026-08-27. Applicant: Ascensia Diabetes Care. Device class: 2.

Clearance details

Device name as filed
CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring System
Applicant
Ascensia Diabetes Care
Product code
Code NBW
Device class
Class 2
Regulation
21 CFR 862.1345
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Valhalla, NY, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code NBW

view all

More clearances from Ascensia Diabetes Care

view all

Adverse events under product code NBW

product code NBW
Death
18
Injury
4,740
Malfunction
42,679
Other
6
Total
47,443

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.